CLINICAL TRIALS PROFILE FOR ACLIDINIUM BROMIDE
✉ Email this page to a colleague
All Clinical Trials for Aclidinium Bromide
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00358436 ↗ | Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD) | Completed | AstraZeneca | Phase 3 | 2006-08-01 | To evaluate the efficacy and safety of LAS 34273 compared to placebo in patients with moderate to severe COPD during one year of treatment. |
NCT00363896 ↗ | A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) | Completed | AstraZeneca | Phase 3 | 2006-07-01 | To evaluate the efficacy and safety of LAS 34273 compared to placebo in patients with moderate to severe COPD during one year of treatment. |
NCT00435760 ↗ | Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients | Completed | AstraZeneca | Phase 3 | 2007-02-01 | This trial evaluates the rate of onset of bronchodilator action of aclidinium bromide compared to placebo and tiotropium in patients with severe COPD after a single dose treatment. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Aclidinium Bromide
Condition Name
Clinical Trial Locations for Aclidinium Bromide
Trials by Country
Clinical Trial Progress for Aclidinium Bromide
Clinical Trial Phase
Clinical Trial Sponsors for Aclidinium Bromide
Sponsor Name